Sign up to save your podcasts
Or
Share Access for rare diseases - how to navigate conflict, compromise and collaboration
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Access for rare diseases - how to navigate conflict, compromise and collaboration
World Orphan Drug Congress panel discussion November 2021
"Access for rare diseases - how to navigate conflict, compromise and collaboration" with panellists -
- Karl Freemyer, Head of Business Development - FIECON (host)
- Martin Schuchardt, Director of Pricing and Market Access - FIECON
- Simon Eade, Vice president of Worldwide global strategy - Janssen
- Oriol Sola-Morales, CEO of Health Innovation Technology Transfer
- Eric Low, CEO - Eric Low Consulting
View all episodes
By FIECONWorld Orphan Drug Congress panel discussion November 2021
"Access for rare diseases - how to navigate conflict, compromise and collaboration" with panellists -
- Karl Freemyer, Head of Business Development - FIECON (host)
- Martin Schuchardt, Director of Pricing and Market Access - FIECON
- Simon Eade, Vice president of Worldwide global strategy - Janssen
- Oriol Sola-Morales, CEO of Health Innovation Technology Transfer
- Eric Low, CEO - Eric Low Consulting